Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Breast Neoplasms and EPCAM[original query] |
|---|
| A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. Breast cancer research and treatment 2011 Apr 126 (2): 487-95. Jiang Lan, Zhang Chun, Li Yinyan, Yu Xiao, Zheng Jian, Zou Ping, Li Yuting, Bin Xiaonong, Lu Jiachun, Zhou Yife |
| PIK3CA mutational status in circulating tumor cells can change during disease recurrence or progression in patients with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Nov 20 (22): 5823-34. Markou Athina, Farkona Sofia, Schiza Christina, Efstathiou Tonia, Kounelis Sophia, Malamos Nikos, Georgoulias Vassilis, Lianidou E |
| A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer. Anticancer research 2015 May 35 (5): 2601-10. Amemiya Yutaka, Bacopulos Stephanie, Al-Shawarby Mohamed, Al-Tamimi Dalal, Naser Walid, Ahmed Ayesha, Khalifa Mahmoud, Slodkowska Elzbieta, Seth Ar |
| Circulating Tumor Cells in Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile and MicroRNA Polymorphisms. Turk patoloji dergisi 2016 32 (3): 148-57. Bansal Cherry, Pujani Mukta, Misra Sanjeev, Srivastava A N, Singh U |
| High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
| Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient. Breast cancer research and treatment 2018 Jul 170 (1): 179-188. Johnson Julie, Bessette Darrell C, Saunus Jodi M, Smart Chanel E, Song Sarah, Johnston Rebecca L, Cocciardi Sibylle, Rozali Esdy N, Johnstone Cameron N, Vargas Ana Christina, Kazakoff Stephen H, BioBank Victorian Cancer, Khanna Kum Kum, Lakhani Sunil R, Chenevix-Trench Georgia, Simpson Peter T, Nones Katia, Waddell Nicola, Al-Ejeh Far |
| New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients. Molecular biology reports 2019 7 46 (5): 5537-5541. Gervas Polina, Klyuch Boris, Denisov Evgeny, Kiselev Artem, Molokov Alexey, Pisareva Lubov, Malinovskaya Elena, Choynzonov Evgeny, Cherdyntseva Nadez |
| Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants. Frontiers in oncology 2020 6 10 666. Nikitin Aleksey G, Chudakova Daria A, Enikeev Rafael F, Sakaeva Dina, Druzhkov Maxim, Shigapova Leyla H, Brovkina Olga I, Shagimardanova Elena I, Gusev Oleg A, Gordiev Marat |
| Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
| No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel Testing. JCO precision oncology 2022 1 4 51-60. Stoll Jessica, Rosenthal Eric, Cummings Shelly, Willmott Jamie, Bernhisel Ryan, Kupfer Sonia |
| Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling. Mutation research 2023 7 827 111831. Zeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzo?lu, Mutlu Do?an, Öztürk Ate?, Ece Esin, ?rem Bilgetekin, Umut Demirci, Ça?lar Köseo?lu, Alper Topal, Nuri Karadurmu?, Haktan Ba??? Erdem, Taha Bah |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. NPJ precision oncology 2024 6 8 (1): 136. Miguel Ruiz-De La Cruz, Héctor Martínez-Gregorio, Clara Estela Díaz-Velásquez, Fernando Ambriz-Barrera, Norma Gabriela Resendiz-Flores, Rina Gitler-Weingarten, María Patricia Rojo-Castillo, Didier Pradda, Javier Oliver, Sandra Perdomo, Eva María Gómez-García, Aldo Hugo De La Cruz-Montoya, Luis Ignacio Terrazas, Gabriela Torres-Mejía, Fidel de la Cruz Hernández-Hernández, Felipe Vaca-Paniag |
- Page last reviewed:Feb 1, 2024
- Content source: